Ricerca avanzata

Arie Belldegrun has a current job as a Director at 6200 Greenwich Drive REIT LLC.

Arie Belldegrun has a current job as a Director at 1685 38th REIT LLC.

Arie S. Belldegrun è un imprenditore e uomo d'affari che ha fondato 6 aziende, tra cui: Kite Pharma, Inc., Allogene Therapeutics, Inc. e Agensys, Inc. e che è stato a capo di 16 diverse aziende. Attualmente ricopre la posizione di presidente e partner di Two River Group Holdings LLC, presidente di Two River Group Management LLC, presidente di Bellco Capital LLC (che ha fondato nel 2003), presidente di Two Rivers Consulting Corp., presidente di UroGen Pharma Ltd., presidente e partner di Two River Consulting LLC, presidente esecutivo di Allogene Therapeutics, Inc. (che ha fondato nel 2017), Presidente di Kronos Bio, Inc., Co-Presidente di Breakthrough Properties LLC, Senior Managing Director di VV Manager LLC (che ha fondato nel 2017), Senior Managing Director di Vida Ventures LLC (che ha fondato nel 2017) (una controllata di VV Manager LLC) e Presidente di Technology Assessment Group. Arie S. Belldegrun è anche direttore e professore all'UCLA Institute of Urologic Oncology, capo della divisione di oncologia urologica alla David Geffen School of Medicine e Senior Managing Director alla Vida Ventures LLC (che ha fondato nel 2017) e nel consiglio di amministrazione di altre 5 società. Il dottor Belldegrun è stato in precedenza presidente di Arno Therapeutics, Inc. e presidente non esecutivo di Arno Therapeutics, Inc. (una filiale di Arno Therapeutics, Inc.), presidente, presidente e amministratore delegato di Equinor ASA, direttore di Agensys, Inc. (ha fondato la società nel 1997), Presidente esecutivo, Presidente e CEO di Kite Pharma, Inc. (ha fondato l'azienda nel 2009), presidente del comitato per la tecnologia biologica molecolare presso l'American Urological Association Education & Research, Inc., ricercatore presso il National Cancer Institute e membro del Los Angeles Economy & Jobs Committee. Arie S. Belldegrun ha conseguito un dottorato presso la Hebrew University Hadassah Medical School e una laurea al Weizmann Institute of Science.

Ron Belldegrun is the founder and the Chief Executive Officer of ByHeart, Inc., a company founded in 2016.
He is also the founder and the Managing Partner of Consumer Health Ventures LLC, which is also founded in 2016.
Mr. Belldegrun previously worked as an Investor at Visium Asset Management LP.
He completed his undergraduate degree at the University of Pennsylvania in 2008.

Ben Belldegrun is the founder of Aliment Capital LLC, where he holds the title of Managing Partner starting in 2014.
He is also the founder of Lodestone BV.
Currently, Mr. Belldegrun holds director positions at Anuvia Plant Nutrients Corp., Concentric Ag Corp., Tropic Biosciences UK Ltd., Pairwise Plants Services, and Concentric Agriculture, Inc. Mr. Belldegrun's former position was as a Portfolio Manager at Brevan Howard Asset Management LLP from 2008 to 2011.
Mr. Belldegrun received his undergraduate degree from The Trustees of Columbia University in The City of New York in 1998 and his MBA from the University of California, Los Angeles in 2004.

Rebecka Belldegrun is the founder of Bellco Capital LLC, where she holds the titles of President & Chief Executive Officer from 2003.
She is also the founder of Intertech Corp.
Dr. Belldegrun's current jobs include Director positions at BabyfirstTV, Breakthrough Properties LLC, Breakthrough Properties Growth Portfolio I LP, Trustee positions at California Institute of Technology and Museum Associates.
Dr. Belldegrun's former jobs include Director positions at First Media Corp.
and Independent Director position at Kronos Bio, Inc. Dr. Belldegrun received an undergraduate degree from Tel-Aviv University.

Dan Belldegrun founded Breakthrough Properties LLC, where he worked as Chief Executive Officer.

Daniel Belldegrun currently works at 1685 38th REIT LLC, as President & Chief Executive Officer.